Cytokinesis is the last step of mitotic cell division that separates the cytoplasm of dividing cells.
Introduction
In all eukaryotic cells, mitosis is the complex cytological process that separates the already duplicated chromosomes in space into two identical sets, ultimately leading to the formation of two fully functional nuclei in distant parts of the cell 1 . Mitosis is followed by cytokinesis, a process that separates the cytoplasm of dividing cells resulting in the formation of two daughter cells 2, 3 . In animals, a contractile ring of filamentous actin and nonmuscle myosin II (NMII) assembles in the equatorial plane of the dividing cells (between the segregated sister chromatids) that splits the cytoplasm during cytokinesis by forming the so-called cleavage furrow. The process is tightly regulated both in space and time in a cell-type specific manner [2] [3] [4] [5] . Cytokinesis inhibitors targeting actin, myosin or other regulatory and structural elements necessary for the proper functioning of the cleavage furrow have not only provided useful information about the function of these elements, but are increasingly recognized as potential drug candidates 6 .
Here we present a cell-based assay that is amenable to the discovery of novel cytokinesis inhibitors. The assay is run in 96-well plates with a total incubation time of 48 hours. We demonstrate the robustness, flexibility and reliability of the assay by using small molecule inhibitors of NMII (blebbistatin, para-aminoblebbistatin and para-nitroblebbistatin) and modulators of actin polymerization with different mechanisms of action (jasplakinolide, cytochalasin D and swinholide A). Blebbistatin is an inhibitor of NMII that blocks cellular blebbing and disrupts directed cell migration 7 . It also blocks cytokinesis by inhibiting the contraction of the cleavage furrow. This results in the accumulation of binucleated cells in the population 7 . Para-nitroblebbistatin and para-aminoblebbistatin are photostable derivatives of blebbistatin with reduced cytotoxicity 8, 9 . Para-aminoblebbistatin also shows highly improved water solubility 9 . Jasplakinolide is a stabilizer of pre-formed actin filaments and an inducer of actin polymerization in vitro 10, 11 . By facilitating filament nucleation and lowering the critical actin concentration, jasplakinolide treatment results in the formation of amorphous actin masses in cultured cells 11 . Cytochalasin D inhibits actin polymerization in vitro by binding to the net polymerizing ends of actin filaments and blocking the addition of new monomers to these sites 12, 13 . It also binds actin monomers, inducing the formation of dimers and thereby increasing the rate, but decreasing the extent of polymerization 14, 15 . In cells, cytochalasin D treatment leads to the disruption of the cytoskeletal actin filament network and the aggregation of actin filaments 16, 17 . The third modulator of actin polymerization, Swinholide A, is a highly potent toxin that rapidly severs actin filaments in vitro 18 , and disrupts the actin cytoskeleton of living cells in vivo 18, 19 .
Materials and Methods
Cell cultures. Frozen aliquots of COS7 cells (cat. CRL-1651, American Type Culture Collection, Manassas, VA) were thawed and immediately diluted ten-fold in culture medium containing 89% Dulbecco's Modified Eagle Medium, 10% Fetal Bovine Serum, and 1% Antibiotic-Antimycotic solution (cat. 11995073, cat. 26140079, and cat. 15240062, Life Technologies Carlsbad, CA). The cell suspension was centrifuged at full speed (7, 197 x g) at 20 ⁰ C for 10 minutes in a refrigerated centrifuge (cat. 5430 R, Eppendorf, Hauppauge, NY). The supernatant was discarded, and the pellet was resuspended in culture medium at a final density of ~50,000 cells/ml. Cells were plated onto 75 cm 2 flasks (cat. 430641U, Corning, Corning, NY) at a density of 500,000 cells/flask. Following 3 days of incubation (37 ⁰ C and 5% CO 2 ), old media was removed from the flasks and the cell layers were washed twice with 5 ml of Dulbecco's phosphate-buffered saline (cat. 14190250, Life Technologies, Carlsbad, CA). Subsequently, 2 ml of Trypsin-EDTA (0.25%) solution (cat. 25200072, Life Technologies, Carlsbad, CA) was added to each flask to dissociate cells. Flasks were incubated at 37 ⁰ C for 10 minutes to allow detachment of cells from the surface. Cell dissociation was further facilitated by pipetting the suspension up and down several times until no cell aggregates were observed by visual inspection under a stereomicroscope. To inhibit trypsin, 8 ml of fresh culture medium was combined with 2 ml of cell suspension. Cell density was determined by counting the cells in a hemocytometer. The suspension was diluted to a density of 20,000 cells/ml. Cells were immediately plated onto flat bottom, 96-well cell culture plates (cat. 25-109, Genesee Scientific, El Cajon, CA) by transferring 100 µl of suspension to each well using a multichannel pipette resulting in a final surface density of 2,000 cells/well. respectively) were determined based on preliminary results. A 2 mM solution of para-aminoblebbistatin in DMSO was also prepared and used as positive control, while pure DMSO was used as a negative control. Third, compound plates were prepared by transferring 2.4 µl of positive and negative controls and compound solutions into each well of a 96-well plate containing 117.6 µl of culture media (50-fold dilution) using a multichannel pipette. Wells in the first and last rows were used exclusively for negative and positive controls. Solutions were mixed by shaking the compound plate for 1 min at room temperature at 1200 rpm using a microplate shaker (cat. 12620-926, VWR, West Chester, PA). A typical plate layout map used for screening experiments is shown in Figure 1 A cytokinesis inhibitor allows nuclei to divide, but blocks the separation of cell bodies, resulting in the formation of bi-and multinucleated cells. The inhibitory effect of compounds can be estimated and compared by calculating the ratio of nuclei to cell numbers in the living cell population. Each living cell must contain at least one nucleus and each nucleus must belong to a living cell in this population. Therefore, "cells" not overlapping with nuclei (potentially misidentified cells) and "nuclei" not overlapping with living cells (dead and potentially misidentified nuclei) were excluded from the calculation of the nuclei-to-cell ratio (NCR). This step was crucial to avoid several artifacts (see Results and Discussion). In addition to cytokinesis inhibition, compounds may show cytotoxic effects, which can affect the primary signal (e.g. through nuclear fragmentation or selective death of multinucleated cells). Therefore, cytotoxicity was also quantified as the ratio of dead nuclei to total nuclei. Dead nuclei must show positive staining for both Hoescht33342 and PI. Therefore, all those objects not showing double labeling were excluded from this calculation. Similarly, the total number of nuclei was calculated as the sum of Hoechst33342 positive nuclei overlapping with cells or overlapping with PI positive nuclei. OriginPro 2017 software (cat. ORGNPRO, OriginLab, Northampton, MA) was used to plot the NCR against the compound concentration and to determine the half maximal effective concentration (EC 50 ) by fitting the 6-point dose-response data to the Hill-equation:
concentration of the compound, Y min is the NCR in the absence of inhibitors, Y max is the extrapolated value of the NCR at 100% inhibition, and Hill is the Hill-constant.
Results and Discussion
The presence of cytokinesis inhibitors in a cell culture leads to the accumulation of bi-and multinucleated cells. For example, treating COS7 cells with 20 µM para-aminoblebbistatin for 24 hours resulted in a cell population where most cells were binucleated ( Fig. 2A ). To visualize the cytoplasm, we used FDA, a membrane-permeant non-fluorescent cell viability dye that is hydrolyzed to fluorescein in living cells 20 by naturally present esterase enzymes 21 . The resulting product fluorescein accumulates in the cytoplasm where it shows a bright green fluorescence 20 , thereby providing an excellent signal-to-noise ratio. Nuclei were visualized by Hoescht33342, a cell-permeable DNA stain 22 . The excitation and emission peaks of Hoescht33342 (ex: 350 nm, em: 461 nm, DNA-bound) and fluorescein (ex: 490 nm, em: 526 nm) are well separated from each other. Therefore, these dyes can be used in parallel in imaging applications. We realized that not all nuclei revealed by Hoescht33342 staining overlapped with living cells (see the highlighted areas in Fig. 2A ). To confirm the identity of these objects, we used a second DNA dye, PI 23 , which is membrane-impermeant 24 . This dye is widely used to stain nuclei of dead cells in a cell population 25 With this strategy, several artifacts resulting from object misidentification could be efficiently avoided.
One main source of such artifacts is the limited solubility of the compounds in culture media. This is generally unknown in screening projects. Aqueous solubility (if available) may not match the solubility in culture media at 37°C. Applying compounds at concentrations higher than the solubility may result in compound precipitation. Precipitates may show fluorescence in one or more channels and may be similar in shape and size to cells or nuclei. Therefore, they are prone to be misidentified as such. To demonstrate the effect of compound precipitation, we treated Para-aminoblebbistatin is known as a non-cytotoxic derivative of the myosin inhibitor blebbistatin, showing greatly improved photostability and solubility 9 , making it optimal as a positive control in our assays. The potency (EC 50 ) of para-aminoblebbistatin was determined in dose-response experiments (Fig. 2C ). An EC 50 of 5. (also known as the screening window coefficient) is a widely used statistical parameter that helps to assess the reliability of screening data 26 . We determined the Z` for a half plate of negative (1% DMSO) and a half plate of positive (1% DMSO, 20 µM para-aminoblebbistatin) controls:
σ p and µ n , µ p are the sample standard deviations and means of the negative and positive controls, respectively (Fig. 2D ). We found a Z`>0.5 (Z`=0.65), which indicates that the assay is excellent for screening purposes 26 .
Next, we treated COS7 cells with dilution series of blebbistatin, para-aminoblebbistatin, para-nitroblebbistatin, jasplakinolide, cytochalasin D or swinholide A. Although these compounds have different molecular targets and mechanisms of action, they all inhibit cytokinesis 7-9, 18, 27, 28 . Accordingly, cells developed similar, bi-and multinucleated phenotypes in response to all compounds ( Fig. 3 ). Although slightly different cellular morphology was observed, our protocol was effective in the quantitation of the multinucleated phenotype in all cases.
Dose-response curves with very steep transitions (Hill-constants between 5.2 and 7.7) were observed ( Fig. 4) . By using only six-step serial 1:2 dilutions and performing every experiment in triplicate, it was possible to obtain reliable EC 50 data for four compounds on a single 96-well plate (For EC 50 values, see Fig. 4 . and the upper right panel in Fig. 5 . See Fig. 1 for plate layout.). Repeated experiments with fresh cell cultures yielded similar EC 50 values (Fig. 5 ). To quantitate the reliability of the assay, linear regression analysis was performed using the data from both runs. A coefficient of determination of 0.998 showed excellent test-retest reliability ( Fig. 5 ).
Note that the "dense sampling" of the dose response curves (1:2 dilutions), together with the observed steep transitions constrain the possible values of the EC 50 in a less than two-fold range, even if other parameters are not well constrained. For example, fixing the Hill-constant at any value from ~5 to arbitrarily high numbers usually yields fits with similar goodness, while only slightly affecting the determined EC 50 . This does not represent a problem if the goal is to estimate the EC 50 accurately. To improve the accuracy of Hill-constant estimation, one would need more data points in the transition zone of the dose response curve, at the cost of fewer compounds being tested in parallel on the same plate. It may also be necessary to fix the Y max to get reasonable fits. Such situations are shown in Fig. 4E and Fig 4F, where cytotoxicity resulted in signal deterioration and limited the useful data available for fitting. Therefore, the Y max was made equal to the average NCR of the positive control and kept fixed during the fitting process.
This strategy assumes that the cell division proceeds at similar rates in all these experiments, which seems to be valid based on the similar maximal NCR ratios observed for blebbistatin derivatives and cytochalasin D, but it may not be universally valid. Even if the validity is questionable, the dense sampling of the dose response curves makes it very unlikely to introduce more than two-fold uncertainty around the EC 50 values.
There are several critical steps in our protocol. First, finding the optimal cell density is crucial.
Low cell density may lead to slow cell growth, unnecessarily long incubation times and insufficient total numbers of cells to estimate the signal accurately (see statistical considerations below). On the other hand, high cell density makes it difficult for any automated algorithm to correctly identify cells due to extensive overlap. This usually leads to an apparent increase of the NCR, as multiple cells are recognized as one cell. Therefore, optimal cell density must be determined in separate experiments for every particular cell line used. For COS7 cells, we found that a surface density of 2,000 cells/well on 96 well plates gave optimal results. 
, where n is the sample size, k is the number of mononucleated cells, and p is the probability of finding a mononucleated cell. Calculating for every possible value yields the probability mass function of the particular distribution.
Probability mass functions calculated for several sample sizes are shown in Fig. 6A . To improve assay quality (to have a Z' > 0.5), it is crucial to obtain "good" estimates of the NCR for every single well. These must be close enough to the true value, e.g. it must fall into the range of true value ± 5%. Since the nature of sampling is probabilistic, the sample size needs to be high enough to achieve this goal. The probabilities of having "good" estimates can be calculated as the sum of the probabilities of all the possible values of the NCR falling into the above defined range (Fig. 6B ). To ensure that there is less than one well on average for each 96-well plate that might be affected by random sampling issues, this probability must be above 99%, which can be achieved by sample sizes >300/well. In this work, imaging was continued until at least 600 cells were detected in each well to make sure that final cell numbers are beyond the 300 cells/well threshold. Unfortunately, this threshold represents one of the highest limitations of the method.
Since it might be necessary to image a significant part of the total area of several wells, further miniaturization (e.g. using 384 well plates) may result in less reliable data, especially when cell loss occurs due to cytotoxicity.
A similar phenotypic high-throughput screen for the identification of novel cytokinesis inhibitors has already been published 29 . In that screen, fixed cells were stained by two dyes to visualize the cytoplasm and nuclei. Compared to our method, this procedure is substantially more time consuming, as it requires multiple staining and washing steps 29 . Moreover, with each of these steps, the risk of losing cells from the surface increases and, because the cells are fixed, cytotoxicity can only be estimated in separate experiments. In contrast, our method directly applies a single staining step with three dyes to living cells, thereby reducing the risk of cell loss and providing cytotoxicity information. Others have used EGFP-α-tubulin mCherry-H2B-labeled
HeLa Kyoto cells to visualize the multinucleated phenotype after treating cells with blebbistatin derivatives 8, 9 . Because these cells express EGFP-α-tubulin in the cytoplasm and mCherry-H2B in nuclei, they do not require any staining before imaging. Although stain-free live cell imaging provides this advantage, one would need to introduce similar genetic modifications to any other cell lines prior to using them in screening experiments. In contrast, our strategy is easily applicable to any cell line. Interestingly, the combination of FDA, PI and Hoechst33342 dyes have recently been used to assess neuronal viability in cerebellar granule neuron cultures 30 . This indicates that the same triple-staining strategy might be useful in different areas of cell biology in the future.
In summary, the cytokinesis assay presented here is amenable to semi high-throughput screening applications. It can identify cytokinesis inhibitors regardless of their molecular target or mechanism of action. It is simple and seems to be compatible with multiple cell lines of interest, optimal cell density) and the cytotoxicity of the compounds tested.
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